The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Pathophysiology of diabetes: An overview
Open accessAbstract
Diabetes mellitus is a chronic heterogeneous metabolic disorder with complex pathogenesis. It is characterized by elevated blood glucose levels or hyperglycemia, which results from abnormalities in either insulin secretion or insulin action or both. Hyperglycemia manifests in various forms with a varied presentation and results in carbohydrate, fat, and protein metabolic dysfunctions. Long-term hyperglycemia often leads to various microvascular and macrovascular diabetic complications, which are mainly responsible for diabetes-associated morbidity and mortality. Hyperglycemia serves as the primary biomarker for the diagnosis of diabetes as well. In this review, we would be focusing on the classification of diabetes and its pathophysiology including that of its various types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107843 · Cited by 10,792
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Reck, M., Rodríguez-Abreu, D., Robinson, A. G., Hui, R., Csőszi, T., Fülöp, A., Gottfried, M., Peled, N., Tafreshi, A., Cuffe, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606774 · Cited by 10,089
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
Borghaei, H., Paz-Ares, L., Horn, L., Spigel, D. R., Steins, M., Ready, N. E., Chow, L. Q., Vokes, E. E., Felip, E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507643 · Cited by 9,335
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
Ferris, R. L., Blumenschein, G., Fayette, J., Guigay, J., Colevas, A. D., Licitra, L., Harrington, K., Kasper, S., Vokes, E. E., Even, C., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602252 · Cited by 5,101
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
Bellmunt, J., de Wit, R., Vaughn, D. J., Fradet, Y., Lee, J.-L., Fong, L., Vogelzang, N. J., Climent, M. A., Petrylak, D. P., Choueiri, T. K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1613683 · Cited by 3,395
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
Gestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Wellcome Trust Case Control Consortium, Zeggini, E., Scott, L. J., Saxena, R., Voight, B. F., Marchini, J. L., Hu, T., de Bakker, P. I., Abecasis, G. R., Almgren, P., et al. (2008) · Nature Genetics · doi:10.1038/ng.120 · Cited by 1,864
Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)
Yamagata, K., Oda, N., Kaisaki, P. J., Menzel, S., Furuta, H., Vaxillaire, M., Southam, L., Cox, R. D., Lathrop, G. M., Boriraj, V. V., et al. (1996) · Nature · doi:10.1038/384455a0 · Cited by 1,614
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
Finland, G. O. T. 1. D. I., Todd, J. A., the Wellcome Trust Case Control Consortium, Walker, N. M., Cooper, J. D., Smyth, D. J., Downes, K., Plagnol, V., Bailey, R., Nejentsev, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2068 · Cited by 1,456
Mortality and cardiovascular disease in type 1 and type 2 diabetes
Rawshani, A., Rawshani, A., Franzén, S., Eliasson, B., Svensson, A.-M., Miftaraj, M., McGuire, D. K., Sattar, N., Rosengren, A., & Gudbjörnsdottir, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608664 · Cited by 1,389
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342
Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177
The Syndromes of Insulin Resistance and Acanthosis Nigricans: Insulin-Receptor Disorders in Man
Kahn, C. R., Flier, J. S., Bar, R. S., Archer, J. A., Gorden, P., Martin, M. M., & Roth, J. (1976) · New England Journal of Medicine · doi:10.1056/nejm197604012941401 · Cited by 1,106
Acquired and Inherited Lipodystrophies
Garg, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra025261 · Cited by 941
Ahlgren, U., Jonsson, J., Jonsson, L., Simu, K., & Edlund, H. (1998) · Genes & Development · doi:10.1101/gad.12.12.1763 · Cited by 918
Early-onset type-ll diabetes mellitus (MODY4) linked to IPF1
Staffers, D. A., Ferrer, J., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng1097-138 · Cited by 882
Mutation in hepatocyte nuclear factor–1β gene (TCF2) associated with MODY
Horikawa, Y., Iwasaki, N., Hara, M., Furuta, H., Hinokio, Y., Cockburn, B. N., Lindner, T., Yamagata, K., Ogata, M., Tomonaga, O., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-384 · Cited by 880
Delépine, M., Nicolino, M., Barrett, T., Golamaully, M., Mark Lathrop, G., & Julier, C. (2000) · Nature Genetics · doi:10.1038/78085 · Cited by 813
Identification of the gene altered in Berardinelli–Seip congenital lipodystrophy on chromosome 11q13
Magré, J., Delépine, M., Khallouf, E., Gedde-Dahl, T., Van Maldergem, L., Sobel, E., Papp, J., Meier, M., Mégarbané, A., BSCL Working Group, et al. (2001) · Nature Genetics · doi:10.1038/ng585 · Cited by 756
Maturity-onset diabetes of the young (MODY): how many cases are we missing?
Shields, B. M., Hicks, S., Shepherd, M. H., Colclough, K., Hattersley, A. T., & Ellard, S. (2010) · Diabetologia · doi:10.1007/s00125-010-1799-4 · Cited by 725
Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression
Hui, J. M., Sud, A., Farrell, G. C., Bandara, P., Byth, K., Kench, J. G., McCaughan, G. W., & George, J. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.08.032 · Cited by 718
Mehta, S. H., Brancati, F. L., Sulkowski, M. S., Strathdee, S. A., Szklo, M., & Thomas, D. L. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-8-200010170-00009 · Cited by 676
Lawrence, J. M., Contreras, R., Chen, W., & Sacks, D. A. (2008) · Diabetes Care · doi:10.2337/dc07-2345 · Cited by 658
Imagawa, A., Hanafusa, T., Miyagawa, J.-I., & Matsuzawa, Y. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420501 · Cited by 652
Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus
Malecki, M. T., Jhala, U. S., Antonellis, A., Fields, L., Doria, A., Orban, T., Saad, M., Warram, J. H., Montminy, M., & Krolewski, A. S. (1999) · Nature Genetics · doi:10.1038/15500 · Cited by 619
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607
Genome–wide association studies provide new insights into type 2 diabetes aetiology
Frayling, T. M. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2178 · Cited by 594
Familial Hyperinsulinism Caused by an Activating Glucokinase Mutation
Glaser, B., Kesavan, P., Heyman, M., Davis, E., Cuesta, A., Buchs, A., Stanley, C. A., Thornton, P. S., Permutt, M. A., Matschinsky, F. M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801223380404 · Cited by 564
Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia
Umpierrez, G., & Korytkowski, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.15 · Cited by 563 · cited 1×
“DKA may also be precipitated by the use of certain drugs including sodium-glucose co-transporter-2 (SGLT2) inhibitors, corticosteroids, and atypical antipsychotics (second-generation antipsychotic drugs).[30,31] In absence of any severe physiological stress conditions, patients with T2DM often do not require any insul…”
BackgroundA subtype of diabetes mellitus associated with a mutation of mitochondrial DNA.
Kadowaki, T., Kadowaki, H., Mori, Y., Tobe, K., Sakuta, R., Suzuki, Y., Tanabe, Y., Sakura, H., Awata, T., Goto, Y.-I., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404073301403 · Cited by 551
Osbak, K. K., Colclough, K., Saint-Martin, C., Beer, N. L., Bellanné-Chantelot, C., Ellard, S., & Gloyn, A. L. (2009) · Human Mutation · doi:10.1002/humu.21110 · Cited by 485
9. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s009 · Cited by 485
Pathogenesis of Type 2 Diabetes Mellitus
Leahy, J. L. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.003 · Cited by 469
Aroda, V. R., Christophi, C. A., Edelstein, S. L., Zhang, P., Herman, W. H., Barrett-Connor, E., Delahanty, L. M., Montez, M. G., Ackermann, R. T., Zhuo, X., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3761 · Cited by 467
Thiazide Diuretics, Potassium, and the Development of Diabetes: A Quantitative Review
Zillich, A. J., Garg, J., Basu, S., Bakris, G. L., & Carter, B. L. (2006) · Hypertension · doi:10.1161/01.hyp.0000231552.10054.aa · Cited by 456
Zimmet, P., Tuomi, T., Mackay, I. R., Rowley, M. J., Knowles, W., Cohen, M., & Lang, D. A. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00275.x · Cited by 413
Stoffel, M., & Duncan, S. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13209 · Cited by 406
Insulin Mutation Screening in 1,044 Patients With Diabetes
Edghill, E. L., Flanagan, S. E., Patch, A.-M., Boustred, C., Parrish, A., Shields, B., Shepherd, M. H., Hussain, K., Kapoor, R. R., Malecki, M., et al. (2008) · Diabetes · doi:10.2337/db07-1405 · Cited by 397
Somatostatinoma Syndrome: Biochemical, Morphologic and Clinical Features
Krejs, G. J., Orci, L., Conlon, J. M., Ravazzola, M., Davis, G. R., Raskin, P., Collins, S. M., McCarthy, D. M., Baetens, D., Rubenstein, A., et al. (1979) · New England Journal of Medicine · doi:10.1056/nejm197908093010601 · Cited by 395
Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction
Ræder, H., Johansson, S., Holm, P. I., Haldorsen, I. S., Mas, E., Sbarra, V., Nermoen, I., Eide, S. Å., Grevle, L., Bjørkhaug, L., et al. (2006) · Nature Genetics · doi:10.1038/ng1708 · Cited by 376
Garg, A. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00414-3 · Cited by 372
Clinical Spectrum Associated with Hepatocyte Nuclear Factor-1β Mutations
Bellanné-Chantelot, C., Chauveau, D., Gautier, J.-F., Dubois-Laforgue, D., Clauin, S., Beaufils, S., Wilhelm, J.-M., Boitard, C., Noël, L.-H., Velho, G., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-7-200404060-00009 · Cited by 358
Taylor, S. I. (1992) · Diabetes · doi:10.2337/diab.41.11.1473 · Cited by 344
Mutations in hepatocyte nuclear factor-1β and their related phenotypes
Edghill, E. L., Bingham, C., Ellard, S., & Hattersley, A. T. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.032854 · Cited by 344
Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype
Hawa, M. I., Kolb, H., Schloot, N., Beyan, H., Paschou, S. A., Buzzetti, R., Mauricio, D., De Leiva, A., Yderstraede, K., Beck-Neilsen, H., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0931 · Cited by 339
ASSOCIATION OF CYTOMEGALOVIRUS INFECTION WITH AUTOIMMUNE TYPE 1 DIABETES
Pak, C., Mcarthur, R., Eun, H.-M., & Yoon, J.-W. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92941-8 · Cited by 321
Hattersley, A. T., Greeley, S. A. W., Polak, M., Rubio-Cabezas, O., Njølstad, P. R., Mlynarski, W., Castano, L., Carlsson, A., Raile, K., Chi, D. V., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12772 · Cited by 319
10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s010 · Cited by 302
Variant Hepatocyte Nuclear Factor 1 is required for visceral endoderm specification
Barbacci, E., Reber, M., Ott, M.-O., Breillat, C., Huetz, F., & Cereghini, S. (1999) · Development · doi:10.1242/dev.126.21.4795 · Cited by 293
Bingham, C., Bulman, M. P., Ellard, S., Allen, L. I. S., Lipkin, G. W., Hoff, W. G. V., Woolf, A. S., Rizzoni, G., Novelli, G., Nicholls, A. J., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/316945 · Cited by 287
Glucokinase as pancreatic beta cell glucose sensor and diabetes gene.
Matschinsky, F., Liang, Y., Kesavan, P., Wang, L., Froguel, P., Velho, G., Cohen, D., Permutt, M. A., Tanizawa, Y., & Jetton, T. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116809 · Cited by 287
Banerji, M. A., Chaiken, R. L., Huey, H., Tuomi, T., Norin, A. J., Mackay, I. R., Rowley, M. J., Zimmet, P. Z., & Lebovitz, H. E. (1994) · Diabetes · doi:10.2337/diab.43.6.741 · Cited by 266
Autoimmune mechanisms in type 1 diabetes
Knip, M., & Siljander, H. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.04.008 · Cited by 263
The Insulin-Pancreatic Acinar Axis
Williams, J. A., & Goldfine, I. D. (1985) · Diabetes · doi:10.2337/diab.34.10.980 · Cited by 262
Aguilar-Bryan, L., & Bryan, J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0029 · Cited by 250
Autoantibodies in type 1 diabetes
Taplin, C. E., & Barker, J. M. (2008) · Autoimmunity · doi:10.1080/08916930701619169 · Cited by 250
SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System
Fadini, G. P., Bonora, B. M., & Avogaro, A. (2017) · Diabetologia · doi:10.1007/s00125-017-4301-8 · Cited by 242
Shepherd, M., Shields, B., Ellard, S., Rubio‐Cabezas, O., & Hattersley, A. T. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02690.x · Cited by 241
The MODY1 gene HNF-4α regulates selected genes involved in insulin secretion
Gupta, R. K., Vatamaniuk, M. Z., Lee, C. S., Flaschen, R. C., Fulmer, J. T., Matschinsky, F. M., Duncan, S. A., & Kaestner, K. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522365 · Cited by 240
Hedderson, M. M., Darbinian, J. A., & Ferrara, A. (2010) · Paediatric and Perinatal Epidemiology · doi:10.1111/j.1365-3016.2010.01140.x · Cited by 240
Long-Term Course of Neonatal Diabetes
von Mühlendah, K. E., & Herkenhoff, H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509143331105 · Cited by 237
Type 1 diabetes associated autoimmunity
Kahaly, G. J., & Hansen, M. P. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.02.017 · Cited by 227
Colclough, K., Bellanne-Chantelot, C., Saint-Martin, C., Flanagan, S. E., & Ellard, S. (2013) · Human Mutation · doi:10.1002/humu.22279 · Cited by 224
Mutations in the Insulin Gene Can Cause MODY and Autoantibody-Negative Type 1 Diabetes
Molven, A., Ringdal, M., Nordbø, A. M., Ræder, H., Støy, J., Lipkind, G. M., Steiner, D. F., Philipson, L. H., Bergmann, I., Aarskog, D., et al. (2008) · Diabetes · doi:10.2337/db07-1467 · Cited by 209
Autoimmune Forms of Hypoglycemia
Lupsa, B. C., Chong, A. Y., Cochran, E. K., Soos, M. A., Semple, R. K., & Gorden, P. (2009) · Medicine · doi:10.1097/md.0b013e3181a5b42e · Cited by 202
Kim, S. K., Selleri, L., Lee, J. S., Zhang, A. Y., Gu, X., Jacobs, Y., & Cleary, M. L. (2002) · Nature Genetics · doi:10.1038/ng860 · Cited by 202
Neonatal diabetes mellitus: a disease linked to multiple mechanisms
Polak, M., & Cavé, H. (2007) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-2-12 · Cited by 197
Additional Autoimmune Disease Found in 33% of Patients at Type 1 Diabetes Onset
Triolo, T. M., Armstrong, T. K., McFann, K., Yu, L., Rewers, M. J., Klingensmith, G. J., Eisenbarth, G. S., & Barker, J. M. (2011) · Diabetes Care · doi:10.2337/dc10-1756 · Cited by 197
Gestational diabetes: risks, management, and treatment options
Kim, C. (2010) · International Journal of Women's Health · doi:10.2147/ijwh.s13333 · Cited by 192
Mutations at the BLK locus linked to maturity onset diabetes of the young and β-cell dysfunction
Borowiec, M., Liew, C. W., Thompson, R., Boonyasrisawat, W., Hu, J., Mlynarski, W. M., El Khattabi, I., Kim, S.-H., Marselli, L., Rich, S. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906474106 · Cited by 189
The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus
Fujimoto, W. Y. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00337-5 · Cited by 183
Vigouroux, C., Magré, J., Vantyghem, M. C., Bourut, C., Lascols, O., Shackleton, S., Lloyd, D. J., Guerci, B., Padova, G., Valensi, P., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1958 · Cited by 180
Bingham, C., Ellard, S., Allen, L., Bulman, M., Shepherd, M., Frayling, T., Berry, P. J., Clark, P. M., Lindner, T., Bell, G. I., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.057003898.x · Cited by 179
Heterozygous ABCC8 mutations are a cause of MODY
Bowman, P., Flanagan, S. E., Edghill, E. L., Damhuis, A., Shepherd, M. H., Paisey, R., Hattersley, A. T., & Ellard, S. (2012) · Diabetologia · doi:10.1007/s00125-011-2319-x · Cited by 177
Gestational diabetes mellitus: Challenges for different ethnic groups
Yuen, L. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i8.1024 · Cited by 176
Agenesis of Human Pancreas due to Decreased Half-Life of Insulin Promoter Factor 1
Schwitzgebel, V. M., Mamin, A., Brun, T., Ritz-Laser, B., Zaiko, M., Maret, A., Jornayvaz, F. R., Theintz, G. E., Michielin, O., Melloul, D., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030046 · Cited by 175
Edghill, E. L., Bingham, C., Slingerland, A. S., Minton, J. A. L., Noordam, C., Ellard, S., & Hattersley, A. T. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01999.x · Cited by 174
Hughes, J. W., Riddlesworth, T. D., DiMeglio, L. A., Miller, K. M., Rickels, M. R., McGill, J. B., & for the T1D Exchange Clinic Network (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2478 · Cited by 173
Luna, B. (2001) · JAMA · doi:10.1001/jama.286.16.1945 · Cited by 173
Vaxillaire, M., & Froguel, P. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0024 · Cited by 167
Accuracy and predictive value of classification schemes for ketosis-prone diabetes
Balasubramanyam, A., Garza, G., Rodriguez, L., Hampe, C. S., Gaur, L., Lernmark, A., & Maldonado, M. R. (2006) · Diabetes Care · doi:10.2337/dc06-0749 · Cited by 166
Bingham, C., Ellard, S., van't Hoff, W. G., Simmonds, H. A., Marinaki, A. M., Badman, M. K., Winocour, P. H., Stride, A., Lockwood, C. R., Nicholls, A. J., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00903.x · Cited by 161
Rubio-Cabezas, O., Minton, J. A. L., Kantor, I., Williams, D., Ellard, S., & Hattersley, A. T. (2010) · Diabetes · doi:10.2337/db10-0011 · Cited by 160
Lampasona, V., Petrone, A., Tiberti, C., Capizzi, M., Spoletini, M., di Pietro, S., Songini, M., Bonicchio, S., Giorgino, F., Bonifacio, E., et al. (2010) · Diabetes Care · doi:10.2337/dc08-2305 · Cited by 159
Rubio‐Cabezas, O., Patch, A., Minton, J. A. L., Flanagan, S. E., Edghill, E. L., Hussain, K., Balafrej, A., Deeb, A., Buchanan, C. R., Jefferson, I. G., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1137 · Cited by 154
Clinical features and treatment of maturity onset diabetes of the young (MODY)
Gardner, D. S.-L., & Tai, E. S. (2012) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s23353 · Cited by 152
Loss-of-Function Mutations in APPL1 in Familial Diabetes Mellitus
Prudente, S., Jungtrakoon, P., Marucci, A., Ludovico, O., Buranasupkajorn, P., Mazza, T., Hastings, T., Milano, T., Morini, E., Mercuri, L., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.05.011 · Cited by 148
Resmini, E., Minuto, F., Colao, A., & Ferone, D. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0112-9 · Cited by 147
Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births
The Early Diabetes Study Group of ISPED, Iafusco, D., Massa, O., Pasquino, B., Colombo, C., Iughetti, L., Bizzarri, C., Mammì, C., Presti, D. L., Suprani, T., et al. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0331-8 · Cited by 145
Insulin Autoimmune Syndrome (Hirata Disease): Clinical Features and Epidemiology in Japan
Uchigata, Y., Eguchi, Y., Takayama-Hasumi, S., & Omori, Y. (1994) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(94)90040-x · Cited by 127
HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved?
Undlien, D. E., Lie, B. A., & Thorsby, E. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(00)02180-6 · Cited by 122
Rakočević, G., & Floeter, M. K. (2011) · Muscle & Nerve · doi:10.1002/mus.23234 · Cited by 120
Yorifuji, T., Nagashima, K., Kurokawa, K., Kawai, M., Oishi, M., Akazawa, Y., Hosokawa, M., Yamada, Y., Inagaki, N., & Nakahata, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0096 · Cited by 118
Homeodomain protein IDX-1: a master regulator of pancreas development and insulin gene expression.
Stoffers, D., Thomas, M. K., & Habener, J. (1997) · Trends in endocrinology and metabolism · doi:10.1016/s1043-2760(97)00008-8 · Cited by 117
Diabetes-Haufigkeit bei Akromegalie und Cushing-Syndrom
Biering, H., Knappe, G., Gerl, H., & Lochs, H. (2000) · Acta Medica Austriaca · doi:10.1046/j.1563-2571.2000.00106.x · Cited by 113
Molecular Scanning of the Insulin Receptor Gene in Syndromes of Insulin Resistance
Krook, A., Kumar, S., Laing, I., Boulton, A. J. M., Wass, J. A. H., & O’Rahilly, S. (1994) · Diabetes · doi:10.2337/diab.43.3.357 · Cited by 112
Maturity-Onset Diabetes of the Young: What Do Clinicians Need to Know?
Kim, S. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.6.468 · Cited by 112
Molecular Genetics of Maturity-onset Diabetes of the Young
Froguel, P., & Velho, G. (1999) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(98)00134-9 · Cited by 110
Latent Autoimmune Diabetes in Adults (LADA)
Naik, R. G., & Palmer, J. P. (2003) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1025148211587 · Cited by 100
Lahtela, J. T., Knip, M., Paul, R., Antonen, J. A., & Salmi, J. (1997) · Diabetes Care · doi:10.2337/diacare.20.1.71 · Cited by 95
Syndromes of Autoimmunity and Hypoglycemia: Autoantibodies Directed Against insulinand Its Receptor
Taylor, S. I., Barbetti, F., Accili, D., Roth, J., & Görden, P. (1989) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30392-x · Cited by 94
Familial Hyperproinsulinemia Due to a Proposed Defect in Conversion of Proinsulin to Insulin
Gruppuso, P. A., Görden, P., Kahn, C. R., Cornblath, M., Zeller, W. P., & Schwartz, R. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409063111003 · Cited by 91
Diabetes in Africans. Part 2: Ketosis-prone atypical diabetes mellitus.
Sobngwi, E., Mauvais‐Jarvis, F., Vexiau, P., Mbanya, J. C., & Gautier, J. F. (2002) · PubMed · Cited by 90
Gloyn, A. L., Cummings, E. A., Edghill, E. L., Harries, L. W., Scott, R. R., Costa, T., Temple, I. K., Hattersley, A. T., & Ellard, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0568 · Cited by 90
Metabolic and immunologic features of Chinese patients with atypical diabetes mellitus.
Tan, K. C. B., Mackay, I. R., Zimmet, P. Z., Hawkins, B. R., & Lam, K. S. L. (2000) · Diabetes Care · doi:10.2337/diacare.23.3.335 · Cited by 85
Maturity onset diabetes of the young: clinical characteristics, diagnosis and management.
Kavvoura, F. K., & Owen, K. R. (2012) · Pediatric endocrinology review · Cited by 73
Diabetes: equity and social determinants.
Whiting, D. R., Unwin, N. C., Roglić, G., Blas, E., & Kurup, A. S. (2010) · Cited by 69
Biason‐Lauber, A., Boehm, B. O., Lang‐Muritano, M., Gauthier, B. R., Brun, T., Wollheim, C. B., & Schoenle, E. J. (2005) · Diabetologia · doi:10.1007/s00125-005-1723-5 · Cited by 69
Noctor, E., Crowe, C., Carmody, L. A., Saunders, J. A., Kirwan, B., O’Dea, A., Gillespie, P., Glynn, L. G., McGuire, B. E., O’Neill, C., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1260 · Cited by 65
Diabetes Mellitus in Pancreatic Cancer and the Need for Diagnosis of Asymptomatic Disease
Bartosch-Härlid, A., & Andersson, R. (2010) · Pancreatology · doi:10.1159/000264676 · Cited by 63
Özbek, M. N., Senée, V., Aydemir, S., Kotan, L. D., Mungan, N. Ö., Yüksel, B., Julier, C., & Topaloglu, A. K. (2010) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00591.x · Cited by 50
Gonsorčíková, L., Průhová, Š., Cinek, O., Ek, J., Pelikánová, T., Jørgensen, T., Eiberg, H., Pedersen, O. B., Hansen, T. F., & Lebl, J. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00379.x · Cited by 47
Lomberk, G. A., Grzenda, A. L., Mathison, A., Escande, C., Zhang, J., Calvo, E. L., Miller, L. J., Iovanna, J., Chini, E. N., Fernández-Zapico, M. E., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.434670 · Cited by 46
Chistiakov, D. A., Voronova, N. V., & Chistiakov, P. A. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.03.002 · Cited by 45
Karjalainen, J., Knip, M., Hy�ty, H., Leinikki, P., Ilonen, J., K��r, M. L., & �kerblom, H. K. (1988) · Diabetologia · doi:10.1007/bf00276847 · Cited by 44
Matsuyoshi, A., Shimoda, S., Tsuruzoe, K., Taketa, K., Chirioka, T., Sakamoto, F., Sakakida, M., Miyamura, N., & Araki, E. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.10.018 · Cited by 41
Impaired Fasting Glucose in Cystic Fibrosis
Frohnert, B. I., Ode, K. L., Moran, A., Nathan, B. M., Laguna, T. A., Holme, B., & Thomas, W. T. B. (2010) · Diabetes Care · doi:10.2337/dc10-0613 · Cited by 41
Bacon, S., Kyithar, M. P., Schmid, J., Rizvi, S. R., Bonner, C., Graf, R., Prehn, J. H. M., & Byrne, M. M. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-13 · Cited by 41
Autoimmune Diabetes Associated With Pembrolizumab: A Review of Published Case Reports
Cheema, A., Makadia, B., Karwadia, T., Bajwa, R., & Hossain, M. (2018) · World Journal of Oncology · doi:10.14740/wjon1085w · Cited by 41
7 Diabetes and adrenal disease
Nestler, J. E., & McClanahan, M. A. (1992) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80169-7 · Cited by 40
García-Herrero, C.-M., Rubio‐Cabezas, O., Azriel, S., Gutierrez‐Nogués, Á., Aragonés, Á., Vincent, O., Campos‐Barros, Á., Argente, J., & Navas, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030518 · Cited by 29
Functional evaluation of the type 1 diabetes (T1D) susceptibility candidate genes
Park, Y. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.043 · Cited by 26
Diagnostic criteria for gestational diabetes mellitus
Cosson, E. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.11.007 · Cited by 26
Price, S., Cole, D. C., & Alcolado, J. C. (2010) · QJM · doi:10.1093/qjmed/hcq127 · Cited by 17
South Asian version of flatbush diabetes mellitus- A case report and review article
Khan, K., & Akram, J. (2009) · International Journal of Medicine and Medical Sciences · doi:10.5897/ijmms.9000224 · Cited by 5
Cited by
Wearable Electrochemical Glucose Sensors in Diabetes Management: A Comprehensive Review
Saha, T., Del Caño, R., Mahato, K., De la Paz, E., Chen, C., Ding, S., Yin, L., & Wang, J. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00078 · Cited by 442
Zubaidi, S. N., Mohd Nani, H., Ahmad Kamal, M. S., Abdul Qayyum, T., Maarof, S., Afzan, A., Mohmad Misnan, N., Hamezah, H. S., Baharum, S. N., & Mediani, A. (2023) · Life · doi:10.3390/life13020353 · Cited by 72
“Lack of glucose in the tissue has led to an increase in thirst, frequent urination, and feelings of hunger [12].”
BackgroundXie, W., Zhang, L., Cheng, J., Wang, Y., Kang, H., & Gao, Y. (2024) · BMC Public Health · doi:10.1186/s12889-024-18131-7 · Cited by 41
“With the evolution of civilization and a subsequent improvement in living standards, the prevalence of global GDM has displayed a significant upward trend, impacting over than 20 million women during pregnancy by 2019 [3, 4].”
BackgroundGarcía-Niño, W. R., Zúñiga-Muñoz, A. M., & Maldonado-Macías, X. P. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178715 · Cited by 1
Metadata
- Authors
- Sameer, A., Banday, M., & Nissar, S.
- Venue
- Avicenna Journal of Medicine
- Publisher
- Georg Thieme Verlag KG
- Published
- 2020
- Volume
- 10
- Issue
- 4
- Pages
- 174
- ISSN
- 2231-0770 (ISSN-L)
- OpenAlex
- W3093248547
- Cited by
- 756
- References
- 135
- FWCI
- 34.50
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.